Tag Archive for ‘Harvard Medical School’
When Congress approved the landmark Medicare Part D program in 2003 to help seniors buy prescription drugs, it slapped on an unusual restriction: The federal government was barred from negotiating cheaper prices for those medicines. The ban on government price bargaining, justified by supporters on free market grounds, has been derided by critics as a giant gift to the drug industry.
Big Pharma has written more than $30 billion in checks in the last 10 years to resolve government allegations of illegal marketing, according to consumer watchdog group Public Citizen. Yet those sums are essentially petty cash for the drug giants, says Public Citizen, amounting to less than 5 percent of the net profits raked in by the 11 largest global pharmaceuticals firms over a similar period.